Learn more

QINGDAO LANSHENGYANG PHARMACEUTICAL BIOTECHNOLOGY CO LTD

Overview
  • Total Patents
    13
  • GoodIP Patent Rank
    128,796
About

QINGDAO LANSHENGYANG PHARMACEUTICAL BIOTECHNOLOGY CO LTD has a total of 13 patent applications. Its first patent ever was published in 2015. It filed its patents most often in China. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are SHANDONG YUXIN PHARMACEUTICAL CO LTD, QINGDAO LANSHENGYANG MEDICAL BIOLOG TECHNOLOGY CO LTD and TIANJIN HANRUI PHARMACEUTICAL CO LTD.

Patent filings in countries

World map showing QINGDAO LANSHENGYANG PHARMACEUTICAL BIOTECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 13

Patent filings per year

Chart showing QINGDAO LANSHENGYANG PHARMACEUTICAL BIOTECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Liu Xuejian 7
#2 Xing Jihua 2
#3 Lu Guangmin 1
#4 Wang Guibin 1
#5 Liu Chuntong 1
#6 Xing Shigang 1

Latest patents

Publication Filing date Title
CN105106216A Drug tadalafil composition capsules for treating impotence of males
CN105125557A Medicinal cefazedone composition for treating infectious diseases
CN105147616A Medicine namely pantoprazole sodium composition dry suspension for treating gastric ulcer
CN105078883A Ambroxol hydrochloride pharmaceutical composition aqueous injection for treating diseases of respiratory system
CN105085543A Sulbactam sodium composition serving as antibacterial drug
CN105085548A Pharmaceutical cefotiam composition for treating infectious diseases
CN105078901A Erdosteine pharmaceutical composition dry suspension for treating diseases of respiratory system
CN105078999A Anti-infective medicine of cefamandole nafate composition
CN105125530A Ambroxol hydrochloride composition for treating respiratory disease
CN105106129A Pharmaceutical lansoprazole composite granules for treating digestive system diseases
CN105106128A Antipyretic, analgesic and anti-inflammatory aspirin composite dry suspension
CN105130979A Drug dasatinib compound for treatment of leukemia and preparation method thereof
CN105125538A Medicinal aztreonam composition for treating bacterial infection